GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioporto AS (OCSE:BIOPOR) » Definitions » Cyclically Adjusted PB Ratio

Bioporto AS (OCSE:BIOPOR) Cyclically Adjusted PB Ratio : 6.13 (As of Jun. 01, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Bioporto AS Cyclically Adjusted PB Ratio?

As of today (2025-06-01), Bioporto AS's current share price is kr1.41. Bioporto AS's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was kr0.23. Bioporto AS's Cyclically Adjusted PB Ratio for today is 6.13.

The historical rank and industry rank for Bioporto AS's Cyclically Adjusted PB Ratio or its related term are showing as below:

OCSE:BIOPOR' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.78   Med: 14.61   Max: 41.68
Current: 6.14

During the past years, Bioporto AS's highest Cyclically Adjusted PB Ratio was 41.68. The lowest was 4.78. And the median was 14.61.

OCSE:BIOPOR's Cyclically Adjusted PB Ratio is ranked worse than
85.4% of 137 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.9 vs OCSE:BIOPOR: 6.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Bioporto AS's adjusted book value per share data for the three months ended in Mar. 2025 was kr0.096. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr0.23 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bioporto AS Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Bioporto AS's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioporto AS Cyclically Adjusted PB Ratio Chart

Bioporto AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.68 13.48 9.87 8.92 6.75

Bioporto AS Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.62 9.22 8.06 6.75 6.03

Competitive Comparison of Bioporto AS's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Bioporto AS's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioporto AS's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Bioporto AS's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Bioporto AS's Cyclically Adjusted PB Ratio falls into.


;
;

Bioporto AS Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Bioporto AS's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.41/0.23
=6.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioporto AS's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Bioporto AS's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.096/120.2000*120.2000
=0.096

Current CPI (Mar. 2025) = 120.2000.

Bioporto AS Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.136 100.300 0.163
201509 0.284 100.200 0.341
201512 0.273 99.800 0.329
201603 0.241 100.200 0.289
201606 0.205 100.600 0.245
201609 0.151 100.200 0.181
201612 0.247 100.300 0.296
201703 0.203 101.200 0.241
201706 0.150 101.200 0.178
201709 0.108 101.800 0.128
201712 0.286 101.300 0.339
201803 0.232 101.700 0.274
201806 0.178 102.300 0.209
201809 0.127 102.400 0.149
201812 0.269 102.100 0.317
201903 0.192 102.900 0.224
201906 0.278 102.900 0.325
201909 0.184 102.900 0.215
201912 0.115 102.900 0.134
202003 0.050 103.300 0.058
202006 0.141 103.200 0.164
202009 0.077 103.500 0.089
202012 0.364 103.400 0.423
202103 0.313 104.300 0.361
202106 0.275 105.000 0.315
202109 0.226 105.800 0.257
202112 0.165 106.600 0.186
202203 0.356 109.900 0.389
202206 0.310 113.600 0.328
202209 0.262 116.400 0.271
202212 0.202 115.900 0.209
202303 0.159 117.300 0.163
202306 0.213 116.400 0.220
202309 0.186 117.400 0.190
202312 0.158 116.700 0.163
202403 0.110 118.400 0.112
202406 0.244 118.500 0.248
202409 0.201 118.900 0.203
202412 0.158 118.900 0.160
202503 0.096 120.200 0.096

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bioporto AS  (OCSE:BIOPOR) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Bioporto AS Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Bioporto AS's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioporto AS Business Description

Traded in Other Exchanges
N/A
Address
Tuborg Havnevej 15, Ground Floor, Hellerup, DNK, DK-2900
Bioporto AS is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's products include the NGAL Test, ELISA kits, Antibodies, and Other products and licenses. Geographically, it derives a majority of its revenue from North America.

Bioporto AS Headlines

No Headlines